Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
Nayoung Han,1,2 Jung Mi Oh,1,3 In-Wha Kim1 1Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea; 2College of Pharmacy, Jeju National University, Jejusi, Jeju Special Self-Governing Province, Republic of Korea; 3College of Pharmacy, Seoul National Univer...
Guardado en:
Autores principales: | Han N, Oh JM, Kim IW |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/120581c1600c45da9d6e317447ef183b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spontaneous reporting of adverse drug reactions: nurses’ perception
por: Erefai Ouassima, et al.
Publicado: (2021) -
Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
por: Hayato Katsuno, et al.
Publicado: (2021) -
Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database
por: Mansour Tobaiqy, et al.
Publicado: (2021) -
Patient-Reported Questionnaires to Identify Adverse Drug Reactions: A Systematic Review
por: Renly Lim, et al.
Publicado: (2021) -
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database
por: Lucia Gozzo, et al.
Publicado: (2021)